Benvic Acquires Custom Compounder Chemres with Focus on Medical Market

Frances’ specialty PVC compounder Benvic has entered the U.S. market through the recent acquisition of custom compounder Chemres, Princeton, N.J. With its compounding operations in Chesapeake, Va., Chemres reportedly has a strong position in the U.S. contact lens market and also has long-term customer relationships in the medical, food and non-food packaging, and wire & cable market sectors. Compounds offered range from those based on polyolefins and PS to PC, ABS, PBT, TPEs and other specialty grades including compounds with PIR and PCR content.

Benvic has specialized in a broad range of PVC compounds and alloys serving industries such as building & construction, wire & cable, packaging, fluid transfer and electro-technical equipment. In 2019, the company acquired Modenplast Medical, an Italian compounder specializing in medical-grade PVC compounds and tubing extrusion. This was followed in 2020 with the acquisition of Luc & Bel, an Italian manufacturer which specializes in the design and manufacture of medical device components, and in 2021 with the acquisition of selected TPE and PP compounding assets from Celanese.

The Chemres acquisition ushers Benvic to the U.S. market and strengthen its exposure to the medical sector, allowing Benvic to become a key global supplier in this market. Benvic will combine its track record of supplying highly innovative solutions with the expertise of Chemres in the North American marketplace and its strong customer portfolio.

The management team of Chemres, led by founder Paul Keimig, are partnering with Benvic to lead Benvic’s growth in North America. Said Benvic Group’s CEO Luc Mertens, “Like Benvic, Chemres is a top performer in the compounding industry; out-performing competitors in growth, quality and client satisfaction. Our shared culture for performance and innovation will enable us to develop new business and technical synergies, and provide us with an exciting strategic opportunity in the U.S. market. We look forward to work closely with the management team of Chemres in the coming years to expand our operations in North America and grow our polymer expertise across sectors and in particular in the medical sector.”

Said Chemres’s CEO Paul Keimig,“Chemres is excited to partner with Benvic in order to accelerate our growth as well as provide additional value for our customers. Benvic’s proven success in similar markets and the desire to use Chemres to grow its portfolio in the U.S. market was key in our decision-making process. With Benvic’s vision to be the global leader, Chemres will accelerate its growth through organic and additional compounding acquisitions in the U.S. market. Together, Benvic Group, through Chemres, will have unparalleled, global capabilities.”